19
3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T76544 | Cyclic SSTR agonist octreotide | ||
Cyclic SSTR agonist octreotide is a Octreotide , serving as the cyclic Somatostatin Receptor SSTR agonist [1] . | |||
T9692 | Paltusotine | Somatostatin | |
Paltusotine is a nonpeptide, small molecule somatostatin type 2 (SST2) receptor agonist with high oral bioavailability. Paltusotine maintains GH and IGF-1 levels in acromegaly patients | |||
TP2207 | Pasireotide Acetate | Somatostatin | |
Pasireotide Acetate is a stable cyclohexapeptide somatostatin mimic | |||
T2584 | Octreotide | SMS 201-995 | Somatostatin |
Octreotide (SMS 201-995) is a potent inhibitor of growth hormone, glucagon, and insulin. | |||
T4119 | Octreotide Acetate | SMS 201995,Longastatin,Sandostatin,SMS 201-995 (acetate) | Somatostatin |
Octreotide Acetate (Sandostatin) is a potent, long-acting synthetic somatostatin octapeptide analog that inhibits secretion of growth hormone. | |||
T13022 | SSTR5 antagonist 2 | Others | |
SSTR5 antagonist 2 is a highly potent, oral active and selective antagonist of somatostatin (receptor) subtype 5 (SSTR5),with potential to treat type 2 diabetes mellitus (T2DM). | |||
T13005 | SSTR5 antagonist 1 | Others | |
SSTR5 antagonist 1 is a selective, and orally available antagonist of somatostatin receptor subtype 5 (SSTR5)(IC50s of 9.6 and 57 nM for hSSTR5 and mSSTR5, respectively). | |||
T13022L | SSTR5 antagonist 2 TFA | Others | |
SSTR5 antagonist 2 TFA is a highly potent, oral active and selective antagonist of somatostatin (receptor) subtype 5 (SSTR5), with potential to treat type 2 diabetes mellitus (T2DM). | |||
TP2045 | CH 275 | ||
Potent somatostatin receptor 1 (sst1) agonist; displays selectivity for sst1 (IC50 values are 30.9 nM, 345 nM, > 1 μM, > 10 μM and > 10μM for human sst1, sst3, sst4, sst2 and sst5 respectively). Attenuates somatostatin r... | |||
T61130 | SSTR4 agonist 3 | ||
SSTR4 agonist 3 is a potent compound that activates the SSTR4 receptor. The SSTR4 receptor is highly expressed in the hippocampus and neocortex, which are regions associated with memory, learning, and Alzheimer's disease... | |||
T60911 | SSTR4 agonist 4 | ||
SSTR4 agonist 4 is a potent SSTR4 agonist that has the potential for the pain research. SSTR4 agonists are effective in rodent models of pain associated with acute and chronic associated anti-peripheral nociceptive and a... | |||
T64119 | SSTR5 antagonist 2 hydrochloride | ||
SSTR5 antagonist 2 hydrochloride is a potent, orally active, selective growth hormone inhibitory hormone (receptor) subtype 5 (SSTR5) antagonist that has shown potential for investigation in type 2 diabetes. | |||
T60784 | SSTR4 agonist 2 | ||
SSTR4 agonist 2 is a potent somatostatin receptor subtype 4 (SSTR4) agonist that has the potential in SSTR4-related medical disorders research. SSTR4 pathway inhibits the processes of nociceptive and inflammatory [1]. | |||
T80238 | NODAGA-LM3 TFA | ||
NODAGA-LM3 TFA, a SSTR2 antagonist, can be radiolabeled with ^68Ga for PET imaging applications, particularly in the visualization of SSTR-positive paragangliomas [1] [2]. | |||
T80237 | NODAGA-LM3 | ||
NODAGA-LM3, when labeled with ^68Ga, serves as a PET imaging agent. As an SSTR2 antagonist, ^68Ga-NODAGA-LM3 is utilized for the visualization of SSTR-positive paragangliomas [1] [2]. | |||
T76980 | Tidutamab | ||
Tidutamab (XmAb-18087) is a humanized and affinity-optimized bispecific antibody (bsAb) targeting SSTR2 binding domain and T-cell binding domain (CD3) . Tidutamab possesses a full Fc domain to maintain long serum half-li... | |||
T78110 | DOTA-LM3 TFA | ||
DOTA-LM3 TFA is a somatostatin receptor (SSTR) antagonist with the molecular structure p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2. It is effectively used in tracing tumors in vivo through iso... | |||
T80155 | DOTA-LM3 | ||
DOTA-LM3 is a somatostatin receptor (SSTR) antagonist, with LM3 denoting the peptide sequence p-Cl-Phe-cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH2. It is utilized in the isotopic labeling of tumors for... | |||
T37109 | BIM-23190 hydrochloride | ||
BIM-23190 hydrochloride, a somatostatin analog, a selective SSRT2 and SSRT5 agonist, exhibits Ki values of 0.34 nM and 11.1 nM for SSTR2 and SSTR5, respectively. BIM-23190 can be used in the study for cancer and acromega... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-06360 | SSTR2/SSTR2B Protein-VLP, Human, Recombinant | Human | HEK293 |
TMPY-00374 | SSTR1 Protein, Human, Recombinant (hFc) | Human | HEK293 |
TMPY-06364 | SSTR2/SSTR2A Protein-VLP, Human, Recombinant | Human | HEK293 |